(Total Views: 293)
Posted On: 07/08/2022 7:59:48 AM
Post# of 18
HERE’S A ROUND-UP ON VERU INC!
$VERU
Veru, Inc. (NASDAQ: VERU) announced positive results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and death.
Here's a quick round-up on the Company! Read on to know more:
https://www.aviseanalytics.com/heres-a-round-up-on-veru-inc/
$VERU
Veru, Inc. (NASDAQ: VERU) announced positive results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and death.
Here's a quick round-up on the Company! Read on to know more:
https://www.aviseanalytics.com/heres-a-round-up-on-veru-inc/
(0)
(0)Scroll down for more posts ▼
